ArticleThe Journal of international medical research2021

Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report.

Hubert Mado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.